A Medical Physicist’s Perspective on the Versatility of ProteusONE
What is the point of view of a medical physicist on the versatility of ProteusONE? In this article, Xuanfeng (Leo) Ding, PhD, the Lead Proton Physicist at Corewell Health’s William Beaumont University Hospital Proton Therapy Center, emphasizes the groundbreaking versatility of the IBA ProteusONE system. In his opinion, the IBA ProteusONE system stands out as the world’s first versatile proton therapy system, used to treat a wide range of cancer sites.
Treating complex cancers with ProteusONE
At the William Beaumont Center, complex patient populations like pediatric cancer patients, patients with head and neck tumors, or with intracranial tumors, which constitute about 50 to 60% of the patient population of the center, are treated on ProteusONE. The system’s versatility allows it to meet diverse and complicated clinical needs of the patient geometry and clinical indications.
Find out more about IBA’s unequaled expertise and ProteusONE's unmatched versatility here.
Advantages of operating the ProteusONE system
ProteusONE operates similarly to a linear accelerator (LINAC), which is a significant advantage for therapists. This means that the staff can perform treatments without the need for constant adjustments or changes in accessories, saving valuable time.
Another standout feature of the IBA ProteusONE is its advanced imaging technology. This system is capable of imaging patients while the treatment couch rotates, providing real-time feedback on patient positioning. This capability is crucial for confirming the accuracy of the setup and correcting any motion that may occur during treatment.
In conclusion, the integration of treatment technology, open gantry and access for the patients, and comprehensive imaging modalities make ProteusONE unique and advanced in proton therapy.
Notes
Disclaimer: The statements of the healthcare professional included in this testimonial reflect only his opinion and personal experience. They do not necessarily reflect the opinion of any institution with whom he is affiliated or IBA.
